As peptide-based therapeutics gain momentum in treating metabolic diseases and obesity, ensuring quality from discovery through QA/QC is critical. Agilent’s comprehensive workflow guide walks you through every step of therapeutic peptide development, from raw material verification and impurity profiling to sequence confirmation and quantitative analysis.
With increasing demand for GLP-1 agonists and other targeted therapies, researchers and manufacturers require tools that deliver speed, sensitivity and reliability. Explore how Agilent solutions can streamline your development pipeline while meeting stringent regulatory requirements.
© 2025, Lyonsdown Limited. Business Reporter® is a registered trademark of Lyonsdown Ltd. VAT registration number: 830519543